Title |
Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: meta-analysis of individual patient data examining the effect of age on outcome in two phase III trials
|
---|---|
Published in |
Supportive Care in Cancer, August 2012
|
DOI | 10.1007/s00520-012-1558-9 |
Pubmed ID | |
Authors |
Luigi Celio, Erminio Bonizzoni, Emilio Bajetta, Silvia Sebastiani, Tania Perrone, Matti S. Aapro |
Abstract |
Data from two randomized trials, evaluating a single-day regimen of palonosetron plus dexamethasone against emesis due to moderately emetogenic chemotherapy, were assessed for the impact of age on outcome in a pooled sample of women receiving anthracycline and/or cyclophosphamide (AC)-containing chemotherapy. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 1 | 3% |
United States | 1 | 3% |
Unknown | 38 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 6 | 15% |
Researcher | 5 | 13% |
Student > Postgraduate | 5 | 13% |
Student > Bachelor | 5 | 13% |
Professor | 3 | 8% |
Other | 9 | 23% |
Unknown | 7 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 43% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 13% |
Agricultural and Biological Sciences | 4 | 10% |
Computer Science | 2 | 5% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Other | 3 | 8% |
Unknown | 8 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2012.
All research outputs
#18,312,024
of 22,673,450 outputs
Outputs from Supportive Care in Cancer
#3,537
of 4,517 outputs
Outputs of similar age
#127,995
of 166,746 outputs
Outputs of similar age from Supportive Care in Cancer
#21
of 28 outputs
Altmetric has tracked 22,673,450 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,517 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 12th percentile – i.e., 12% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,746 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.